<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Clinical observation and management of COVID-19 patients Emerging Microbes &amp;amp;" exact="Infections" post="T. Li et al. LiTaishengaLuHongzhoubZhangWenhongcCONTACT[a], Department of Infectious Diseases,"/>
 <result pre="Microbes &amp;amp; Infections T. Li et al. LiTaishengaLuHongzhoubZhangWenhongcCONTACT[a], Department of" exact="Infectious" post="Diseases, Peking Union Medical College Hospital, Peking Union Medical"/>
 <result pre="Shanghai Public Health Clinical CenterPeople’s Republic of China[c], Department of" exact="Infectious" post="Diseases, Huashan Hospital, Shanghai Medical College, Fudan UniversityPeople’s Republic"/>
 <result pre="Fudan UniversityPeople’s Republic of China CONTACT Wenhong Zhang zhangwenhong@fudan.edu.cnDepartment of" exact="Infectious" post="Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai"/>
 <result pre="Shanghai 200040, People’s Republic of China Taisheng Li litsh@263.netDepartment of" exact="Infectious" post="Diseases, Peking Union Medical College Hospital, Peking Union Medical"/>
 <result pre="the original work is properly cited.TEMI_9_1741327.pdf Abstract ABSTRACT Three leading" exact="infectious disease" post="experts in China were invited to share their bedside"/>
 <result pre="original work is properly cited.TEMI_9_1741327.pdf Abstract ABSTRACT Three leading infectious" exact="disease" post="experts in China were invited to share their bedside"/>
 <result pre="For severe or critically ill patients, in addition to the" exact="respiratory" post="supportive treatment, timely multiorgan evaluation and treatment is very"/>
 <result pre="February 2020. While the overall mortality rate for SARS-CoV-2 seems" exact="lower" post="than SARS or MERS, the death rate among severe"/>
 <result pre="range of efforts to develop special treatments for COVID-19 with" exact="limited" post="success. In the current commentary, EMI invited three leading"/>
 <result pre="limited success. In the current commentary, EMI invited three leading" exact="infectious disease" post="experts in China who have personally participated in the"/>
 <result pre="success. In the current commentary, EMI invited three leading infectious" exact="disease" post="experts in China who have personally participated in the"/>
 <result pre="not high, due to the widespread of the disease, the" exact="total" post="number of deaths is not small. Based on my"/>
 <result pre="COVID-19 When SARS-CoV-2 infects a person, the lesions are not" exact="limited" post="to the lungs. The virus causes viraemia after entering"/>
 <result pre="through the bloodstream and mainly in the lungs, gastrointestinal tract," exact="and heart," post="presumably concentrated in the tissues expressing ACE2, the receptor"/>
 <result pre="main cause of the aggravation of symptoms. At this time," exact="pulmonary" post="lesions became worse, and chest CT scans show imaging"/>
 <result pre="of symptoms. At this time, pulmonary lesions became worse, and" exact="chest" post="CT scans show imaging changes consistent with COVID-19. At"/>
 <result pre="show imaging changes consistent with COVID-19. At this stage, the" exact="peripheral" post="blood lymphocytes decrease significantly, involving both T and B"/>
 <result pre="blood lymphocytes decrease significantly, involving both T and B lymphocytes." exact="Inflammatory" post="factors in peripheral blood are increased. Abnormal coagulation status"/>
 <result pre="significantly, involving both T and B lymphocytes. Inflammatory factors in" exact="peripheral" post="blood are increased. Abnormal coagulation status Patients at this"/>
 <result pre="hypercoagulable state in patients. During the development of dyspnoea and" exact="chest" post="imaging changes from light to severe, the D-dimer increased"/>
 <result pre="at the same time as the organ functions of the" exact="heart" post="and kidneys became worse. The above manifestations are consistent"/>
 <result pre="design What we are faced with is a newly discovered" exact="viral" post="disease, testing drugs are selected mainly based on the"/>
 <result pre="of Seasonal Febrile Diseases.&quot; In the diagnosis and treatment of" exact="acute" post="respiratory infectious diseases like SARS and influenza, traditional Chinese"/>
 <result pre="Seasonal Febrile Diseases.&quot; In the diagnosis and treatment of acute" exact="respiratory" post="infectious diseases like SARS and influenza, traditional Chinese medicine"/>
 <result pre="Febrile Diseases.&quot; In the diagnosis and treatment of acute respiratory" exact="infectious diseases" post="like SARS and influenza, traditional Chinese medicine has played"/>
 <result pre="COVID-19 patients Currently, there have been more than 330 laboratory-confirmed" exact="adult" post="cases of COVID-19 in Shanghai [7]. Most patients (&amp;gt;90%)"/>
 <result pre="helping the human body to clear the SARS-CoV-2 viruses, the" exact="disease" post="severity rate in Shanghai (26 cases, around 9–10%) actually"/>
 <result pre="We found that in addition to the involvement of the" exact="respiratory" post="system, critically ill patients often had systemic involvement of"/>
 <result pre="involvement of the respiratory system, critically ill patients often had" exact="systemic" post="involvement of multiple organs, including the heart, kidney, and"/>
 <result pre="including the heart, kidney, and coagulation system in the early" exact="disease" post="course. Sometimes multiple system involvement was observed even at"/>
 <result pre="time of initial hospital admission. Therefore, in addition to the" exact="respiratory" post="supportive treatment, timely multiorgan evaluation and treatment is very"/>
 <result pre="of healthcare providers which includes at least a pulmonologist, an" exact="infectious diseases" post="expert, a critical care specialist, and an ECMO specialist"/>
 <result pre="0.9% in Shanghai. However, we have found that once the" exact="disease" post="course progressed to the critical illness state (requiring mechanical"/>
 <result pre="Based on our experiences, stably mild patients could self-manage the" exact="infection" post="effectively and corticosteroid would not be recommended for them"/>
 <result pre="the 2019 novel human-pathogenic coronavirus isolated from a patient with" exact="atypical" post="pneumonia after visiting Wuhan. Emerg Microb Infect. 2020;9:221–236. doi:"/>
 <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting Wuhan. Emerg Microb Infect. 2020;9:221–236. doi: 10.1080/22221751.2020.1719902"/>
 <result pre="mNGS approach identifies a novel human coronavirus from two individual" exact="pneumonia" post="cases in 2019 Wuhan outbreak. Emerg Microb Infect. 2020;9:313–319."/>
 <result pre="Infect. 2020;9:386–389. doi: 10.1080/22221751.2020.1729071 4ChenWL, LanY, YuanXZ, et al.Detectable 2019-nCoV" exact="viral" post="RNA in blood is a strong indicator for the"/>
 <result pre="Coronavirus, Peking Union Medical College HospitalDiagnosis and clinical management of" exact="Severe" post="Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational"/>
 <result pre="Peking Union Medical College HospitalDiagnosis and clinical management of Severe" exact="Acute" post="Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation"/>
 <result pre="Union Medical College HospitalDiagnosis and clinical management of Severe Acute" exact="Respiratory" post="Syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of"/>
 <result pre="Medical College HospitalDiagnosis and clinical management of Severe Acute Respiratory" exact="Syndrome" post="Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking"/>
 <result pre="of SARS-CoV-2 infection–a review of immune changes in patients with" exact="viral pneumonia." post="Emerg Microb Infect. 2020. 7AiJ, ZhangY, ZhangH, et al.Era"/>
</results>
